Sex ratio of multiple sclerosis in Canada: a longitudinal study.
about
High nationwide incidence of multiple sclerosis in SwedenTemporal trends in the incidence of multiple sclerosis: a systematic reviewEnvironmental risk factors for multiple sclerosis. Part II: Noninfectious factorsIntravenous immunoglobulin to prevent relapses during pregnancy and postpartum in multiple sclerosisOptimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of actionApplications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseasesNeuroendocrine immunoregulation in multiple sclerosisEnvironmental risk factors for multiple sclerosis: a review with a focus on molecular mechanismsMolecular pathogenesis of neuromyelitis opticaNeed for a paradigm shift in therapeutic approaches to CNS injuryIs Multiple Sclerosis an Autoimmune Disease?Congenital Abnormalities and Multiple SclerosisVitamin D Actions on CD4(+) T Cells in Autoimmune DiseaseThe role of epigenetic mechanisms and processes in autoimmune disordersPrevalence and Incidence of Multiple Sclerosis in Fars Province, Southern IranExcess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational StudyPregnancy, sex and hormonal factors in multiple sclerosis.Pregnancy and multiple sclerosis.The postnatal maternal environment affects autoimmune disease susceptibility in A/J mice.What went wrong? The flawed concept of cerebrospinal venous insufficiency.New data identify an increasing sex ratio of multiple sclerosis in Sweden.Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada.Distinguishing Susac's syndrome from multiple sclerosis.An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosisNo effect of preterm birth on the risk of multiple sclerosis: a population based study.The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the futureThe causal cascade to multiple sclerosis: a model for MS pathogenesis.Sex-dependent treatment of chronic EAE with partial MHC class II constructs.Parent-of-origin effect in multiple sclerosis: observations from interracial matings.Pregnancy in multiple sclerosis: a questionnaire study.The genetic basis of multiple sclerosis: a model for MS susceptibility.Smoking and multiple sclerosis: an updated meta-analysisEnvironmental factors and multiple sclerosis severity: a descriptive study.Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin DamageEnhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.Multiple sclerosis susceptibility alleles in African Americans.Multiple sclerosis, vitamin D, and HLA-DRB1*15.Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator.Paediatric UK demyelinating disease longitudinal study (PUDDLS).Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study.
P2860
Q21131936-CC0D9398-B628-4EA4-B892-073ECD21A973Q22241655-82E8B0F1-92FA-43D1-B576-0448EA5E7B5EQ22252931-0329C231-5F64-4C8D-8512-F88B7153363AQ24201599-E3D40454-89AC-4BB7-BD70-961EC287CD11Q26822611-F23E74AD-1F47-43F3-A4EA-E79B3856F819Q26860077-FF389682-F9B8-4D46-8264-E2A5E564CDC9Q26864449-348FF47E-B9C6-49BA-866A-044D794AAA86Q27006548-EB46D595-7A1C-475C-B8B0-C0B41F586647Q27021535-494397DF-6E33-4ACA-AE7E-0BE8BC0613E3Q27025042-6F69B713-026E-4746-90F5-A17DF2D3F486Q27496011-9AA8E102-0B65-409D-9C9F-5F934F7C706CQ27496682-7C447D86-09DA-4098-A606-B31BC6CC076AQ28081150-3E4998E5-EBBA-4894-A0D1-6B93C0B1B742Q28389137-D7763CD9-B097-404F-8BF1-D709989183A7Q28607748-CDC9D623-1D73-4C2A-8748-567722342FA6Q30000077-4467F1DA-B10E-4341-AA16-914E55E96918Q30354175-C91CEEEC-75E5-4CC3-BCB7-6AEFA5CDD618Q30375612-231097E6-B8A8-4FF9-BEAB-DE18221B9B4EQ30433603-4A8AA24D-DF6C-497D-B9C8-5665E215EC14Q30454634-45F30EFC-89DA-4E75-8243-B6BFC9E5068AQ30824442-80DCBA09-CA04-43B9-90F4-968D0E29B1F1Q30869199-F64AA764-1A49-4D8D-9FD8-5759599E167EQ30882185-59C6E22B-09EC-420B-8DC1-A0F63A99709AQ31002774-44F593DE-1021-4CD8-9F85-4385B80F2AA1Q33357046-9B8EDD32-FA0C-4356-A839-5CE9EE1BAEC7Q33397837-03871CBA-45AE-4491-A248-8395EFB29338Q33412374-329AA528-02E5-41BF-9B39-0DF1EA8BD2D8Q33645392-4202EDAA-C37E-47DD-A8F2-49C714FAFF93Q33698089-7D7B7FD9-A572-468A-8566-C2E4CBEB8800Q33717231-3E5DB881-564F-49C7-AECC-770F4747F749Q33732130-6A1D5F07-A1CB-4DB2-9A01-080E15B92C31Q33797795-1A783BC5-EBC3-424A-B75C-968E18942976Q33834066-0A24FA03-141E-469F-B8F2-5AE25E6EE63CQ33838894-2D815771-ECA7-4CA3-8D93-9B0BD4BB7B70Q33872502-19576B0B-E5CE-4CC1-9A5A-E29FDA65CDEEQ33892035-1C39328E-EA94-4637-A0F2-878734A4BC3BQ33899907-34CBDD0D-F7D7-4EDD-8555-48BA11C572AAQ33908337-CB91C80B-7050-43E3-B87C-DC1A04DE459DQ33974317-FC94FDA9-48BE-45BD-AD41-19CF87FD8508Q34040939-3F8E1EAD-8D66-4BDC-9EAF-D08BEF18A887
P2860
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
@en
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
@nl
type
label
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
@en
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
@nl
prefLabel
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
@en
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
@nl
P2093
P1433
P1476
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
@en
P2093
A Dessa Sadovnick
Blanca M Herrera
Canadian Collaborative Study Group
Irene M Yee
Sarah-Michelle Orton
Sreeram V Ramagopalan
William Valdar
P304
P356
10.1016/S1474-4422(06)70581-6
P577
2006-11-01T00:00:00Z